Related Experiment Video
Updated: Jul 16, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Pneumococcal endocarditis in children: a nationwide survey in Japan
Naruhiko Ishiwada1, Koichiro Niwa, Shigeru Tateno
1Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan. ishiwada@faculty.chiba-u.jp
Insights
Pediatric infective endocarditis (IE) caused by Streptococcus pneumoniae often involves severe infections and penicillin-resistant strains. Carbapenem shows effectiveness in treating this serious condition in children.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Infective endocarditis (IE) caused by Streptococcus pneumoniae has a high mortality rate.
- Limited data exists on pediatric pneumococcal IE and established optimal therapies.
- This study aimed to define clinical features of pediatric pneumococcal IE via a Japanese nationwide survey.
Purpose of the Study:
- To identify the clinical characteristics of pediatric infective endocarditis (IE) caused by Streptococcus pneumoniae.
- To analyze the treatment and outcomes of children diagnosed with pneumococcal IE.
- To inform the development of management strategies for pediatric pneumococcal IE.
Main Methods:
- A 5-year nationwide survey (1997-2001) registered 170 pediatric IE cases.
- Nine cases (5.3%) of pneumococcal IE were identified and analyzed.
- Clinical course, treatment, and outcomes of 9 pediatric patients (aged 7 months to 4 years) were retrospectively reviewed.
Main Results:
- Pneumococcal IE was linked to congenital heart disease in 7 patients and systemic infections (meningitis, pneumonia, otitis media) in 4.
- Penicillin-resistant Streptococcus pneumoniae strains accounted for 55.6% of isolates.
- Seven patients received carbapenem; three required cardiac surgery; one patient died from septic shock.
Conclusions:
- Pediatric pneumococcal endocarditis frequently presents with severe systemic infections.
- Penicillin-resistant strains are common in pediatric cases.
- Carbapenem therapy is effective against penicillin-resistant Streptococcus pneumoniae in IE.
Background:
Infective endocarditis (IE) due to Streptococcus pneumoniae (S. pneumoniae) carries a high mortality rate. However, little is known about pneumococcal IE in children and no optimal therapy has been established. Thus, we attempted to identify the clinical features of this disorder through a Japanese nationwide survey.
Methods:
Members of the Japanese Society of Pediatrics Cardiology and Cardiac Surgery registered 170 pediatric patients with IE diagnosed during a 5-year period (1997-2001). Nine of these patients (5.3%) had pneumococcal IE. The clinical course, treatment and outcome of these 9 patients, aged 7 months to 4 years, were analyzed.
Results:
Pneumococcal IE was associated with congenital heart disease in 7 patients and accompanied by other systemic infections including meningitis, pneumonia and otitis media, in 4 patients. Five of the 9 (55.6%) strains isolated by blood culture were penicillin-resistant S. pneumoniae strains. Seven patients were treated with carbapenem. Three underwent cardiac surgery due to cardiac failure and/or vegetation. One died due to septic shock on the first day of hospitalization.
Conclusions:
In children, pneumococcal endocarditis is often accompanied by severe systemic infections. The majority of pediatric cases are caused by penicillin-resistant S. pneumoniae strains. Carbapenem is an effective for IE caused by penicillin-resistant S. pneumoniae. This survey might be helpful to establish proper management strategies for pediatric pneumococcal IE.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Respiratory Syncytial Virus Disease
Endocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
